Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade

Immune checkpoint blockade with anti-PD-1 antibodies is showing great promise for patients with metastatic melanoma and other malignancies, but despite good responses by some patients who achieve partial or complete regression, many others still do not respond. Here, we sought peripheral blood T-cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Bochem, Jonas, Zelba, Henning, Amaral, Teresa, Spreuer, Janine, Soffel, Daniel, Eigentler, Thomas, Wagner, Nikolaus Benjamin, Uslu, Ugur, Terheyden, Patrick, Meier, Friedegund, Garbe, Claus, Pawelec, Graham, Weide, Benjamin, Wistuba-Hamprecht, Kilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697319/
https://www.ncbi.nlm.nih.gov/pubmed/31419253
http://dx.doi.org/10.1371/journal.pone.0221301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697319/
https://www.ncbi.nlm.nih.gov/pubmed/31419253
http://dx.doi.org/10.1371/journal.pone.0221301

Ejemplares similares